Their study showed the successful use of a simple new tuberculosis vaccine to help fight the most common type of bladder cancer by boosting patients' immune responses, proving the potential of ...

A CASE of the “world’s deadliest infectious disease” has been detected in an East Sussex primary school – prompting a ...

GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.

Citation: Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence, pilot study suggests (2025, March 22) retrieved 14 April 2025 from https://medicalxpress ...

According to the deputy president, South Africa is among the 30 countries accounting for 87% of the global TB burden.

The other headline-making TB vaccine candidate, M72, achieved efficacy of around 50% in phase 2 trials. That vaccine requires two jabs given a month apart, as opposed to the single shot with MTBVAC.

European tuberculosis surveillance report underscores the gravity of the situation in the WHO European region.1 Across 53 ...

has asked for more safety data from the makers of two tuberculosis (TB) vaccine candidates—VPM1002 and Immuvac—after reviewing the results of their phase-3 trials. VPM1002 is a recombinant BCG ...

But a bungling medic mixed up the vaccines and gave her a shot of the vaccine against tuberculosis (TB) - unwittingly infecting with her one of the world's most deadly diseases. Known as the ...